In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
A Senate hearing probed whether the Food and Drug Administration's process for approving rare-disease therapies is ...
Molecule AI is revolutionising drug discovery by using artificial intelligence to predict molecular combinations and significantly reduce development costs.
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
Clinical trials are not just about testing medicines; they are about building the future of healthcare There is a dire need ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...
Rare genetic diseases such as ataxia telangiectasia and cystic fibrosis lack strong commercial incentives, prompting ...
1don MSN
Smart materials and drug delivery could exploit lipid molecules that reorganize at drying interfaces
Minor changes in moisture level can promote lipid molecules to reorganize themselves in biomaterial or biomembranes. This can affect how the skin, lungs and tear film protect us from dehydration. This ...
In an effort to battle against what members feel is an existential threat to their business, a group of 10 domestic biotech companies have launched the Midsized Biotech Alliance of America with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results